Pharming Group NV
NASDAQ:PHAR

Watchlist Manager
Pharming Group NV Logo
Pharming Group NV
NASDAQ:PHAR
Watchlist
Price: 16.61 USD 0.12% Market Closed
Market Cap: 1.1B USD

Net Margin
Pharming Group NV

0%
Current
-2%
Average
-6.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
100k
/
Revenue
362.3m

Net Margin Across Competitors

No Stocks Found

Pharming Group NV
Glance View

Market Cap
1.1B USD
Industry
Biotechnology

Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The company is headquartered in Leiden, Zuid-Holland and currently employs 321 full-time employees. The firm is engaged in the development, production and commercialization of human therapeutic proteins to be used in the therapies. The firm's product portfolio is aimed at treatments for genetic disorders, blood-related disorders, infectious and inflammatory diseases, tissue and bone damage and surgical/traumatic bleeding. Its core product, RUCONEST (conestat alfa) is a recombinant human C1 esterase inhibitor approved for the treatment of acute Hereditary Angioedema (HAE) attacks in patients in Europe, the Unites States, Israel and South Korea. The product is available on a named-patient basis in other territories where it has not yet obtained marketing authorization.

PHAR Intrinsic Value
18.12 USD
Undervaluation 8%
Intrinsic Value
Price
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
100k
/
Revenue
362.3m
What is the Net Margin of Pharming Group NV?

Based on Pharming Group NV's most recent financial statements, the company has Net Margin of 0%.

Back to Top